Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Preparation of metal phthalocyanine (MPc)-polymer complexes: the possible anti-cancer properties of FePc-polymer complexes.

Inamura I, Inamura K, Jinbo Y, Mihara T, Sasaoka Y.

Heliyon. 2019 Mar 29;5(3):e01383. doi: 10.1016/j.heliyon.2019.e01383. eCollection 2019 Mar.

2.

Cerebral Thromboembolism after Lobectomy for Lung Cancer: Pathological Diagnosis and Mechanism of Thrombus Formation.

Hashimoto H, Usui G, Tsugeno Y, Sugita K, Amori G, Morikawa T, Inamura K.

Cancers (Basel). 2019 Apr 5;11(4). pii: E488. doi: 10.3390/cancers11040488. Review.

3.

A case report on 111In chloride bone marrow scintigraphy in management of adrenal myelolipoma.

Yamamoto T, Koizumi M, Kohno A, Numao N, Inamura K.

Medicine (Baltimore). 2019 Feb;98(8):e14625. doi: 10.1097/MD.0000000000014625.

4.

Mesenchymal tumors of the lung: diagnostic pathology, molecular pathogenesis, and identified biomarkers.

Hashimoto H, Tsugeno Y, Sugita K, Inamura K.

J Thorac Dis. 2019 Jan;11(Suppl 1):S9-S24. doi: 10.21037/jtd.2018.12.04. Review.

5.

Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA.

Haga Y, Uemura M, Baba S, Inamura K, Takeuchi K, Nonomura N, Ueda K.

Anal Chem. 2019 Feb 5;91(3):2247-2254. doi: 10.1021/acs.analchem.8b04829. Epub 2019 Jan 23.

PMID:
30669833
6.

Gut microbiome: a key player in cancer immunotherapy.

Shigematsu Y, Inamura K.

Hepatobiliary Surg Nutr. 2018 Dec;7(6):479-480. doi: 10.21037/hbsn.2018.10.02. No abstract available.

7.

SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance.

Wasserman I, Lee LH, Ogino S, Marco MR, Wu C, Chen X, Datta J, Sadot E, Szeglin B, Guillem JG, Paty PB, Weiser MR, Nash GM, Saltz L, Barlas A, Manova-Todorova K, Uppada SPB, Elghouayel AE, Ntiamoah P, Glickman JN, Hamada T, Kosumi K, Inamura K, Chan AT, Nishihara R, Cercek A, Ganesh K, Kemeny NE, Dhawan P, Yaeger R, Sawyers CL, Garcia-Aguilar J, Giannakis M, Shia J, Smith JJ.

Clin Cancer Res. 2019 Mar 15;25(6):1948-1956. doi: 10.1158/1078-0432.CCR-18-1726. Epub 2018 Dec 26.

PMID:
30587545
8.

Unique MicroRNA and mRNA Interactions in EGFR-Mutated Lung Adenocarcinoma.

Subat S, Inamura K, Ninomiya H, Nagano H, Okumura S, Ishikawa Y.

J Clin Med. 2018 Nov 6;7(11). pii: E419. doi: 10.3390/jcm7110419.

9.

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.

Shigematsu Y, Inamura K, Yamamoto N, Mise Y, Saiura A, Ishikawa Y, Takahashi S, Kanda H.

BMC Cancer. 2018 Oct 16;18(1):980. doi: 10.1186/s12885-018-4902-8.

10.

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.

PMID:
30228205
11.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Hamada T, Liu L, Nowak JA, Mima K, Cao Y, Ng K, Twombly TS, Song M, Jung S, Dou R, Masugi Y, Kosumi K, Shi Y, da Silva A, Gu M, Li W, Keum N, Wu K, Nosho K, Inamura K, Meyerhardt JA, Nevo D, Wang M, Giannakis M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

Eur J Cancer. 2018 Nov;103:98-107. doi: 10.1016/j.ejca.2018.07.130. Epub 2018 Sep 13.

PMID:
30219720
12.

CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining.

Inamura K, Shigematsu Y, Ninomiya H, Nakashima Y, Kobayashi M, Saito H, Takahashi K, Futaya E, Okumura S, Ishikawa Y, Kanda H.

Cancers (Basel). 2018 Jul 31;10(8). pii: E252. doi: 10.3390/cancers10080252.

13.

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer.

Inamura K, Takazawa Y, Inoue Y, Yokouchi Y, Kobayashi M, Saiura A, Shibutani T, Ishikawa Y.

J Clin Med. 2018 Jul 10;7(7). pii: E172. doi: 10.3390/jcm7070172.

14.

TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.

Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, Morikawa T, Inamura K, Shukla SA, Wu CJ, Garraway LA, Zhang X, Wu K, Meyerhardt JA, Chan AT, Glickman JN, Rodig SJ, Freeman GJ, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Oncoimmunology. 2018 Mar 19;7(7):e1442999. doi: 10.1080/2162402X.2018.1442999. eCollection 2018.

15.
16.

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan.

Shigematsu Y, Inamura K, Mise Y, Saiura A, Rehnberg E, Yamamoto N, Ishikawa Y, Takahashi S, Kanda H.

Oncotarget. 2018 Mar 30;9(24):17056-17065. doi: 10.18632/oncotarget.24842. eCollection 2018 Mar 30.

17.

Bladder Cancer: New Insights into Its Molecular Pathology.

Inamura K.

Cancers (Basel). 2018 Apr 1;10(4). pii: E100. doi: 10.3390/cancers10040100. Review.

18.

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.

Inamura K.

Oncotarget. 2018 Feb 16;9(18):14723-14737. doi: 10.18632/oncotarget.24515. eCollection 2018 Mar 6. Review.

19.

Update on Immunohistochemistry for the Diagnosis of Lung Cancer.

Inamura K.

Cancers (Basel). 2018 Mar 14;10(3). pii: E72. doi: 10.3390/cancers10030072. Review.

20.

Genetic Mechanisms of Immune Evasion in Colorectal Cancer.

Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, Morikawa T, Nosho K, Abril-Rodriguez G, Connolly C, Escuin-Ordinas H, Geybels MS, Grady WM, Hsu L, Hu-Lieskovan S, Huyghe JR, Kim YJ, Krystofinski P, Leiserson MDM, Montoya DJ, Nadel BB, Pellegrini M, Pritchard CC, Puig-Saus C, Quist EH, Raphael BJ, Salipante SJ, Shin DS, Shinbrot E, Shirts B, Shukla S, Stanford JL, Sun W, Tsoi J, Upfill-Brown A, Wheeler DA, Wu CJ, Yu M, Zaidi SH, Zaretsky JM, Gabriel SB, Lander ES, Garraway LA, Hudson TJ, Fuchs CS, Ribas A, Ogino S, Peters U.

Cancer Discov. 2018 Jun;8(6):730-749. doi: 10.1158/2159-8290.CD-17-1327. Epub 2018 Mar 6.

PMID:
29510987

Supplemental Content

Loading ...
Support Center